Tag: ASX: NSB
NeuroScientific begins cell therapy manufacturing transfer to Q-Gen
NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) has commenced the transfer of its patented cell manufacturing process to Q-Gen Cell Therapeutics, a move the company says is a key step in advancing its clinical development and commercialisation plans.
Featured Article
Responding to manufacturing demand and performance signals
Australian manufacturers are navigating a challenging environment. Just as output had returned to growth, higher fuel and freight costs, rising input prices and global supply chain disruption renewed pressure on margins and cash flow.
